[Our experience in the treatment of progressive muscular dystrophy].
D000293:Adolescent; D000328:Adult; D045930:Anabolic Agents / Q000627:therapeutic use*; D001224:Aspartic Acid / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D007294:Inositol / Q000627:therapeutic use*; D008297:Male; D008715:Methionine / Q000627:therapeutic use*; D008875:Middle Aged; D009136:Muscular Dystrophies / Q000188:drug therapy*; D009711:Nucleotides / Q000627:therapeutic use*; D014810:Vitamin E / Q000627:therapeutic use*
D045930:Anabolic Agents; D009711:Nucleotides; D014810:Vitamin E; D001224:Aspartic Acid; D007294:Inositol; D008715:Methionine
La nostra esperienza nel trattamento della distrofia muscolare progressiva.